Business

GSK, Zhifei sign £2.5bn deal for shingles vaccine in China

GSK has announced an agreement with China’s largest vaccine firm, Zhifei,  by revenue, to increase global sales of its shingles vaccine by 2026. According to the Financial Times, the UK-based pharmaceutical company said Zhifei had agreed to acquire £2.5 billion worth of GSK’s blockbuster shot, Shingrix, which is targeted at older individuals, over three years. If GSK’s […]